Placement Announced
Werewolf Therapeutics placement
US$150m raised
Announced 21 Aug 2026 · NASDAQ: HOWL
Advisers
Werewolf Therapeutics
Issuer
Not disclosed
Lead managers
- Legal adviser
- Issuer
- Werewolf Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development, Rare Disease
Similar deals
- Research Alliance Corporation III placement Jul 2026 · US$100m · Biotech
- Ambros Therapeutics placement Aug 2026 · US$150m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Jasper Therapeutics placement Jul 2026 · US$132m · Biotech
- Scribe Therapeutics IPO Jul 2026 · US$129m · Biotech


